Pdt Partners, LLC Horizon Therapeutics Public LTD CO Transaction History

Pdt Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$79.4 - $116.36 $1.76 Million - $2.57 Million	-22,111 Reduced 27.68%	57,763 $4.61 Million
Q1 2022 May 16, 2022	BUY	$86.42 - $109.81 $1.58 Million - $2.01 Million	18,297 Added 29.71%	79,874 $8.4 Million
Q4 2021 Feb 14, 2022	BUY	$98.56 - $119.91 $5.17 Million - $6.29 Million	52,477 Added 576.67%	61,577 $6.64 Million
Q3 2021 Nov 15, 2021	SELL	$91.91 - $110.37 $65,164 - $78,252	-709 Reduced 7.23%	9,100 $997,000
Q2 2021 Aug 16, 2021	BUY	$86.24 - $95.92 $845,928 - $940,879	9,809 New	9,809 $919,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Pdt Partners, LLC with notifications on news.